EVEEVE HEALTH GROUP LIMITED.Market sensitive

EVE Advances Reformulated Drugs Targeting Global Markets

Date and time
Announcement type
Company Update

More from Financials

CGFMergers & Acquisitions19 October 2026

Challenger (ASX: CGF) Receives $11.80-a-Share Takeover Proposal

More News